Developing Novel Oncolytic Adenoviruses through Bioselection
Open Access
- 15 February 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (4) , 2675-2685
- https://doi.org/10.1128/jvi.77.4.2640-2650.2003
Abstract
The equine herpesvirus 1 (EHV-1) immediate-early (IE) and EICP0 proteins are potent trans-activators of EHV-1 promoters; however, in transient-transfection assays, the IE protein inhibits the trans-activation function of the EICP0 protein. Assays with IE mutant proteins revealed that its DNA-binding domain, TFIIB-binding domain, and nuclear localization signal may be important for the antagonism between the IE and EICP0 proteins. In vitro interaction assays with the purified IE and EICP0 proteins indicated that these proteins interact directly. At late times postinfection, the IE and EICP0 proteins colocalized in the nuclei of infected equine cells. Transient-transfection assays showed that the EICP0 protein trans-activated EHV-1 promoters harboring only a minimal promoter region (TATA box and cap site), suggesting that the EICP0 protein trans-activates EHV-1 promoters by interactions with general transcription factor(s). In vitro interaction assays revealed that the EICP0 protein interacted directly with the basal transcription factors TFIIB and TBP and that the EICP0 protein (amino acids [aa] 143 to 278) mediated the interaction with aa 125 to 174 of TFIIB. Our unpublished data showed that the IE protein interacts with the same domain (aa 125 to 174) of TFIIB and with TBP. Taken together, these results suggested that interaction of the EICP0 protein with the IE protein, TFIIB, and TBP may mediate the antagonism between the IE and EICP0 proteins.Keywords
This publication has 72 references indexed in Scilit:
- Analyses of Single-Amino-Acid Substitution Mutants of Adenovirus Type 5 E1B-55K ProteinJournal of Virology, 2001
- A herpes simplex virus type 1 mutant deleted for γ34.5 and LAT kills glioma cells in vitro and is inhibited for in vivo reactivationCancer Gene Therapy, 2001
- Expansion of tropism of a feline parvovirus to target a human tumor cell line by display of an αv integrin binding peptide on the capsidGene Therapy, 2001
- Evaluation of E1-Mutant Adenoviruses as Conditionally Replicating Agents for Cancer TherapyMolecular Therapy, 2000
- Gene delivery from replication-selective viruses: arming guided missiles in the war against cancerJournal of Clinical Investigation, 2000
- Molecular evolution of aphthovirusesVirus Genes, 1995
- Isolation and partial characterization of a human adenovirus type 4 temperature-sensitive mutant (Mastadenovirus h 4 tsl)Canadian Journal of Microbiology, 1984
- Controls of RNA splicing and termination in the major late adenovirus transcription unitNature, 1981
- Adenovirus early gene products may control viral mRNA accumulation and translation in vivoCell, 1981
- Isolation of Temperature-sensitive Mutants of Adenovirus Type 5Journal of General Virology, 1971